Trial Profile
Bimatoprost in the Treatment of Eyelash Hypotrichosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Jun 2019
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Hypotrichosis
- Focus Registrational; Therapeutic Use
- Sponsors Allergan
- 23 May 2014 New trial record
- 21 Mar 2014
- 01 Nov 2013